Our Stem Cell Transplant Stories
Smart Cells were the first private UK stem cell storage company to release samples for use in transplants for treatment of illness and disease.
At some point your child may need stem cell treatment – whether that’s for a blood cancer, genetic disorder, brain injury or something as common as a sports injury or skin condition.
Smart Cells has now released more samples for clinical use than any other private storage company in the UK with a 100 per cent success rate. These have been used by patients all around the world to treat a range of conditions including Cerebral Palsy, Thalassemia, Leukaemia, and HSV Encephalitis.
This significant milestone for the industry highlights the advances being made in stem cell research, a service many parents-to-be are not yet aware of. Smart Cells is working to change that – and help more parents protect their children’s wellbeing and future.
Smart Cells have released 21 samples to six countries.
Stem cells hold the key to more than 80 life-changing treatments, with clinical trials underway on many more. Replacing damaged cells and tissue, they can even save a child’s life.
100% success rate
For samples released for transplant.
3 months – 12 yrs old
Stored cord blood samples have been successfully released for use in transplant for children aged as little as 3 months to 12 years old.
48% self | 52% siblings
Smart Cells have successfully released stored cord blood samples that have been used for treatment with the child it was collected from and also siblings.
Conditions Treated
Medical condition | Sample release date | Recipient relationship | Recipient age | Unit volume | Medical centre | Country |
---|---|---|---|---|---|---|
Leukaemia | Nov 2006 | Allogeneic (Sibling) | Restricted | Restricted | Stem Cells and Immunology Department, Birmingham | UK |
Leukaemia | Jan 2014 | Allogeneic (Sibling) | 4 Years | 71ml | Medizinische Hochschule, Hanover | Germany |
Thalassemia | Nov 2005 | Allogeneic (Sibling) | 4 Years | 144ml | Mount Vernon Hospital | Singapore |
Thalassemia | Feb 2007 | Allogeneic (Sibling) | 7 Years | 76ml | Kinderlink der Tu Munchen | Germany |
Thalassemia | Oct 2013 | Allogeneic (Sibling) | 5 Years | 58ml | Catherine Lewis Centre, Hammersmith | UK |
Thalassemia | Nov 2015 | Allogeneic (Sibling) | 12 Years | 87ml | Children’s Hospital of Pittsburgh of UPMC | USA |
Cerebral Palsy | Aug 2009 | Autologous (Self) | 3 Years | 51ml | Duke University, North Carolina | USA |
Cerebral Palsy | Jan 2010 | Autologous (Self) | 3 Years | 81ml | Duke University, North Carolina | USA |
Cerebral Palsy | May 2014 | Autologous (Self) | 1 year | 68ml | Duke University, North Carolina | USA |
Cerebral Palsy | Mar 2016 | Allogeneic (Sibling) | 6 Years | 101ml | Duke University, North Carolina | USA |
Cerebral Palsy | Jun 2017 | Autologous (Self) | 7 Years | 82ml | Duke University, North Carolina | USA |
Cerebral Palsy | Jun 2017 | Autologous (Self) | 3.5 Years | 132ml | Duke University, North Carolina | USA |
Cerebral Palsy | Jun 2019 | Allogeneic (Sibling) | 3 Years | 104ml | Duke University, North Carolina | USA |
Autism | Mar 2018 | Autologous (Self) | 5.4 Years | 73ml | Duke University, North Carolina | USA |
Acute Lymphocytic Leukaemia | Apr 2011 | Allogeneic (Sibling) | 8 Years | 130ml | Royal Marsden Hospital | UK |
Lymphoblastic Leukaemia (^1) | Apr 2017 | N/A (Identical twin girls) | Restricted | 125ml | Bambin Gesu Childrens’ Hospital, Rome | Italy |
HSV Encephalitis & NMDA Receptor Antibody Virus | Jun 2014 | Autologous (Self) | 2 Years | 57ml | Duke University, North Carolina | USA |
Sickle Cell Disease | May 2015 | Allogeneic (Sibling) | 2 .5 Years | 57ml | BLK Hospital, New Delhi | India |
Hypoxic Ischemic Encephalopathy (HIE) | Aug 2014 | Autologous (Self) | 3 Months | 39ml | Duke University, North Carolina | USA |
Hypoxic Ischemic Encephalopathy (HIE) | Feb 2015 | Autologous (Self) | 6 Months | 53ml | Duke University, North Carolina | USA |
Severe Combined Immune Deficiency | Mar 2015 | Autologous (Self) | 3 Months | 74ml | Duke University, North Carolina | USA |
(^1) Cord blood unit released by SCI used to help define the origin of acute lymphoblastic leukaemia in twins
Learn more
Shamshad Ahmed
Founder & CEO of Smart Cells International Ltd
“The number of samples we have released signifies that stem cell technology is one of the most exciting areas of medical science in our time. The fact that we have released more samples in the past ten years than we did in the first ten years shows this evolving area is making big steps in a positive direction.”
Ready to get started or need more information?